Biomerica Statistics
Total Valuation
Biomerica has a market cap or net worth of $9.37 million. The enterprise value is $6.85 million.
Important Dates
The last earnings date was Monday, April 14, 2025, after market close.
| Earnings Date | Apr 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomerica has 2.55 million shares outstanding. The number of shares has increased by 8.37% in one year.
| Current Share Class | 2.55M |
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | +8.37% |
| Shares Change (QoQ) | +12.06% |
| Owned by Insiders (%) | 5.96% |
| Owned by Institutions (%) | 8.70% |
| Float | 2.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.47 |
| Forward PS | n/a |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.76 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -72.70% and return on invested capital (ROIC) is -43.24%.
| Return on Equity (ROE) | -72.70% |
| Return on Assets (ROA) | -35.99% |
| Return on Invested Capital (ROIC) | -43.24% |
| Return on Capital Employed (ROCE) | -89.07% |
| Revenue Per Employee | $88,719 |
| Profits Per Employee | -$75,781 |
| Employee Count | 64 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, Biomerica has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.01% in the last 52 weeks. The beta is 0.37, so Biomerica's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -37.01% |
| 50-Day Moving Average | 5.20 |
| 200-Day Moving Average | 3.50 |
| Relative Strength Index (RSI) | 39.56 |
| Average Volume (20 Days) | 28,526 |
Short Selling Information
The latest short interest is 186,009, so 7.31% of the outstanding shares have been sold short.
| Short Interest | 186,009 |
| Short Previous Month | 49,683 |
| Short % of Shares Out | 7.31% |
| Short % of Float | 7.77% |
| Short Ratio (days to cover) | 0.90 |
Income Statement
In the last 12 months, Biomerica had revenue of $5.68 million and -$4.85 million in losses. Loss per share was -$2.14.
| Revenue | 5.68M |
| Gross Profit | 762,000 |
| Operating Income | -5.10M |
| Pretax Income | -6.30M |
| Net Income | -4.85M |
| EBITDA | -5.02M |
| EBIT | -5.10M |
| Loss Per Share | -$2.14 |
Full Income StatementBalance Sheet
The company has $3.06 million in cash and $543,000 in debt, giving a net cash position of $2.52 million or $0.99 per share.
| Cash & Cash Equivalents | 3.06M |
| Total Debt | 543,000 |
| Net Cash | 2.52M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 5.53M |
| Book Value Per Share | 2.17 |
| Working Capital | 4.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.22 million and capital expenditures -$24,000, giving a free cash flow of -$4.25 million.
| Operating Cash Flow | -4.22M |
| Capital Expenditures | -24,000 |
| Free Cash Flow | -4.25M |
| FCF Per Share | -$1.67 |
Full Cash Flow StatementMargins
Gross margin is 13.42%, with operating and profit margins of -89.84% and -85.42%.
| Gross Margin | 13.42% |
| Operating Margin | -89.84% |
| Pretax Margin | -85.36% |
| Profit Margin | -85.42% |
| EBITDA Margin | -88.32% |
| EBIT Margin | -89.84% |
| FCF Margin | n/a |